The impact of Oncotype DX testing on breast cancer management and chemotherapy prescribing patterns in a tertiary referral centre

INTRODUCTION: The use of chemotherapy in node-negative, (O)Estrogen Receptor (ER)-positive breast cancer has changed significantly since the introduction of Oncotype DX to determine systemic recurrence risk based on tumour genomic signature. AIMS: This study aims to: 1. Document longitudinal changes...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: McVeigh, Terri Patricia, Hughes, Lauren M., Miller, Nicola, Sheehan, Margaret, Keane, Maccon, Sweeney, Karl J., Kerin, Michael J.
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier Science Ltd 2014
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4204201/
https://ncbi.nlm.nih.gov/pubmed/25240289
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ejca.2014.08.002
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados